2025-12-20 - Analysis Report
Here's a breakdown of Tempus AI (TEM) based on the provided data, including analysis and summaries:

**0) Introduction**

We will analyze Tempus AI (TEM) by examining its return rate compared to the S&P 500 (VOO), recent stock price fluctuations, market risk indicators, and recent news/analyst opinions.

**1) Return Rate vs. S&P 500 (VOO)**

*   **Company Overview:** Tempus AI Inc. is a technology company focused on precision medicine through data and artificial intelligence.
*   **TEM Cumulative Return:** 15.06%
*   **VOO Cumulative Return:** 30.11%
*   **Divergence:** -15.05%
*   **Relative Divergence:** 28.8

**Analysis:** Tempus AI has significantly underperformed the S&P 500 (VOO) over the analyzed period. The current divergence suggests TEM is lagging behind the broader market. The relative divergence indicates that the current difference is near the lower end of the historical range between TEM and VOO.

**Alpha, Beta Analysis:**

|            | CAGR  | MDD   | Alpha   | Beta | Cap(B) |
|------------|-------|-------|---------|------|--------|
| 2023-2025  | 15.0% | 76.7% | -14.0% | 0.3  | 11.5   |

*   **CAGR (Compound Annual Growth Rate):** 15.0% indicates the average annual growth rate of the investment over the period.
*   **MDD (Maximum Drawdown):** 76.7% signifies a substantial potential loss from peak to trough.
*   **Alpha:** -14.0% means the investment has underperformed its benchmark (market index) on a risk-adjusted basis.
*   **Beta:** 0.3 indicates the investment is less volatile than the market, moving only 30% as much as the market index.
*   **Cap(B):** 11.5B refers to the market capitalization of the company, which is $11.5 billion.

**2) Recent Stock Price Fluctuations**

*   **Current Price:** \$64.46
*   **Previous Close:** \$62.21
*   **Change:** 3.62%
*   **5-day SMA:** \$65.61
*   **20-day SMA:** \$72.86
*   **60-day SMA:** \$80.13

**Analysis:** The stock price is currently below all three moving averages (5-day, 20-day, and 60-day), suggesting a recent downtrend. However, the positive change in the last market indicates a potential rebound.

**3) Market Risk Indicators**

*   **MRI (Market Risk Indicator):** 0.7 (Medium Investment Recommended)
*   **RSI (Relative Strength Index):** 23.89 (Oversold)
*   **PPO (Percentage Price Oscillator):** -1.42
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (14 shares - Very Safe - MRI:0.90) Monthly invest 5.0% of total investment ($1,000.00) (Cash Ratio: 0% on 2025-12-01)
*   **Recent (20 days) relative divergence change:** -11.0 (negative: short-term decline)
*   **Expected Return (%):** NaN

**Analysis:**

*   **MRI:** A medium investment recommendation suggests a moderate level of risk and potential reward.
*   **RSI:** The RSI indicates the stock is oversold, potentially signaling a buying opportunity.
*   **PPO:** The negative PPO suggests the stock's short-term momentum is weaker than its long-term momentum.
*   **Hybrid Signal:** The signal recommends allocating all available cash to buy the stock, viewing it as very safe.
*   **Divergence Change:** The recent decrease in relative divergence confirms the short-term downward trend.
*   **Expected Return:** The lack of expected return data hinders long-term investment analysis.

**4) Recent News & Significant Events (Yahoo Finance)**

*   **Positive Headlines:** Several articles highlight Tempus AI's potential for profitability and long-term upside, citing analyst optimism and Cathie Wood's investment. Upgrades have been observed, indicating the stock is now performing as expected.
*   **FDA Clearance & Revenue Growth:** News mentions opinions on FDA clearance and revenue growth, suggesting potential positive catalysts for the stock.
*   **Executive Sale:** An executive selling shares could be interpreted negatively, but further context is needed to assess the significance.

**4-2) Analyst Opinions**

*   **Consensus:** Buy (Mean: 2.14)
*   **Opinions:** 12
*   **Target Price:** \$90.17 (Avg), \$105.00 (High), \$80.00 (Low)
*   **Recent Rating Changes:** Not available.

**Analysis:** Analysts generally have a positive outlook on Tempus AI, with a consensus "Buy" rating and a significant upside potential based on the average target price.

**5) Comprehensive Analysis**

Tempus AI has underperformed the S&P 500 and is currently in a downtrend, as indicated by its price being below its moving averages and a negative relative divergence change. However, the oversold RSI and positive analyst sentiment suggest a potential for a rebound. Recent news highlights the company's potential for profitability and long-term growth, while an executive selling shares introduces a note of caution.

**Summary & Recommendation:**

*   **Short-Term:** Be cautious due to the recent downtrend and underperformance. The oversold RSI suggests a potential buying opportunity, but confirmation is needed.
*   **Long-Term:** The positive analyst outlook, potential for profitability, and long-term growth prospects make Tempus AI an interesting stock to watch. The high Maximum Drawdown indicates a high risk of loss, while the low Beta indicates that it is less volatile than the market.
*   **Overall:** A medium investment is recommended, but only if the investor is aware of the risk of loss.

*Disclaimer: This analysis is based on the provided data and should not be considered financial advice. Conduct thorough research and consult with a financial advisor before making any investment decisions.*


**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.